Chemokine cooperativity is caused by competitive glycosaminoglycan binding

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3908-3914

  Verkaar, Folkert ^a,b   Van Offenbeek, Jody ^a,b   Van Der Lee, Miranda M C ^b   Van Lith, Lambertus H C J ^b   Watts, Anne O ^a   Rops, Angelique L W M M ^c   Aguilar, David C ^d   Ziarek, Joshua J ^e,h   Van Der Vlag, Johan ^c   Handel, Tracy M ^d   Volkman, Brian F ^e   Proudfoot, Amanda E I ^f   Vischer, Henry F ^a   Zaman, Guido J R ^g   Smit, Martine J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f MERCK SERONO S A   (Switzerland)

^g Netherlands Translational Research Center BV   (Netherlands)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BINDING, COMPETITIVE; CHEMOKINE CCL19; CHEMOKINE CCL21; CHEMOKINE CXCL13; CHEMOKINES; CHEMOTAXIS; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSAMINOGLYCANS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTORS, CHEMOKINE;

EID: 84898636375     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302159     Document Type: Article

References (46)

1. Lohse, M. J., J. L. Benovic, J. Codina, M. G. Caron, and R. J. Lefkowitz. 1990. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248: 1547-1550.
2. Canals, M., D. J. Scholten, S. de Munnik, M. K. Han, M. J. Smit, and R. Leurs. 2012. Ubiquitination of CXCR7 controls receptor trafficking. PLoS One 7: e34192.
3. Watts, A. O., F. Verkaar, M. M. van der Lee, C. A. Timmerman, M. Kuijer, J. van Offenbeek, L. H. van Lith, M. J. Smit, R. Leurs, G. J. Zaman, and H. F. Vischer. 2013. b-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR. J. Biol. Chem. 288: 7169-7181.
4. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
5. Bai, Z., H. Hayasaka, M. Kobayashi, W. Li, Z. Guo, M. H. Jang, A. Kondo, B. I. Choi, Y. Iwakura, and M. Miyasaka. 2009. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J. Immunol. 182: 1287-1295.
6. Gouwy, M., S. Struyf, J. Catusse, P. Proost, and J. Van Damme. 2004. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J. Leukoc. Biol. 76: 185-194.
7. Gouwy, M., S. Struyf, S. Noppen, E. Schutyser, J. Y. Springael, M. Parmentier, P. Proost, and J. Van Damme. 2008. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 74: 485-495.
8. Kuscher, K., G. Danelon, S. Paoletti, L. Stefano, M. Schiraldi, V. Petkovic, M. Locati, B. O. Gerber, and M. Uguccioni. 2009. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Eur. J. Immunol. 39: 1118-1128.
9. Sebastiani, S., G. Danelon, B. Gerber, and M. Uguccioni. 2005. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine. Eur. J. Immunol. 35: 746-756.
10. Paoletti, S., V. Petkovic, S. Sebastiani, M. G. Danelon, M. Uguccioni, and B. O. Gerber. 2005. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105: 3405-3412.
11. Krug, A., R. Uppaluri, F. Facchetti, B. G. Dorner, K. C. Sheehan, R. D. Schreiber, M. Cella, and M. Colonna. 2002. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169: 6079-6083.
12. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Brière, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
13. Gosling, J., D. J. Dairaghi, Y. Wang, M. Hanley, D. Talbot, Z. Miao, and T. J. Schall. 2000. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell-and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164: 2851-2856.
14. Townson, J. R., and R. J. Nibbs. 2002. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/ mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR. Eur. J. Immunol. 32: 1230-1241.
15. O'Boyle, G., P. Mellor, J. A. Kirby, and S. Ali. 2009. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J. 23: 3906-3916.
16. Severin, I. C., J. P. Gaudry, Z. Johnson, A. Kungl, A. Jansma, B. Gesslbauer, B. Mulloy, C. Power, A. E. Proudfoot, and T. Handel. 2010. Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. J. Biol. Chem. 285: 17713-17724.
17. Ziarek, J. J., A. E. Getschman, S. J. Butler, D. Taleski, B. Stephens, I. Kufareva, T. M. Handel, R. J. Payne, and B. F. Volkman. 2013. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery. ACS Chem. Biol. 8: 1955-1963.
18. Ziarek, J. J., C. T. Veldkamp, F. Zhang, N. J. Murray, G. A. Kartz, X. Liang, J. Su, J. E. Baker, R. J. Linhardt, and B. F. Volkman. 2013. Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. J. Biol. Chem. 288: 737-746.
19. Feng, L. Y., Z. L. Ou, F. Y. Wu, Z. Z. Shen, and Z. M. Shao. 2009. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin. Cancer Res. 15: 2962-2970.
20. Verkaar, F., J. W. van Rosmalen, M. Blomenröhr, C. J. van Koppen, W. M. Blankesteijn, J. F. Smits, and G. J. Zaman. 2008. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors. Biotechnol. Annu. Rev. 14: 253-274.
21. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968.
22. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
23. Amara, A., O. Lorthioir, A. Valenzuela, A. Magerus, M. Thelen, M. Montes, J. L. Virelizier, M. Delepierre, F. Baleux, H. Lortat-Jacob, and F. Arenzana-Seisdedos. 1999. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274: 23916-23925.
24. Veldkamp, C. T., C. Seibert, F. C. Peterson, N. B. De la Cruz, J. C. Haugner, III, H. Basnet, T. P. Sakmar, and B. F. Volkman. 2008. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci. Signal. 1: ra4.
25. Drury, L. J., J. J. Ziarek, S. Gravel, C. T. Veldkamp, T. Takekoshi, S. T. Hwang, N. Heveker, B. F. Volkman, and M. B. Dwinell. 2011. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc. Natl. Acad. Sci. USA 108: 17655-17660.
26. Zhang, L., R. Lawrence, B. A. Frazier, and J. D. Esko. 2006. CHO glycosylation mutants: proteoglycans. Methods Enzymol. 416: 205-221.
27. de Paz, J. L., E. A. Moseman, C. Noti, L. Polito, U. H. von Andrian, and P. H. Seeberger. 2007. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2: 735-744.
28. Okada, T., V. N. Ngo, E. H. Ekland, R. Förster, M. Lipp, D. R. Littman, and J. G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196: 65-75.
29. Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95: 258-263.
30. Ansel, K. M., V. N. Ngo, P. L. Hyman, S. A. Luther, R. Förster, J. D. Sedgwick, J. L. Browning, M. Lipp, and J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309-314.
31. Hargreaves, D. C., P. L. Hyman, T. T. Lu, V. N. Ngo, A. Bidgol, G. Suzuki, Y. R. Zou, D. R. Littman, and J. G. Cyster. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194: 45-56.
32. Mazzucchelli, L., A. Blaser, A. Kappeler, P. Schärli, J. A. Laissue, M. Baggiolini, and M. Uguccioni. 1999. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104: R49-R54.
33. Hjelmström, P., J. Fjell, T. Nakagawa, R. Sacca, C. A. Cuff, and N. H. Ruddle. 2000. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156: 1133-1138.
34. Pablos, J. L., A. Amara, A. Bouloc, B. Santiago, A. Caruz, M. Galindo, T. Delaunay, J. L. Virelizier, and F. Arenzana-Seisdedos. 1999. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 155: 1577-1586.
35. Adams, D. H., and A. R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349: 490-495.
36. Mahalingam, S., and G. Karupiah. 1999. Chemokines and chemokine receptors in infectious diseases. Immunol. Cell Biol. 77: 469-475.
37. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
38. Taylor, K. R., and R. L. Gallo. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20: 9-22.
39. Sasisekharan, R., Z. Shriver, G. Venkataraman, and U. Narayanasami. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2: 521-528.
40. Lortat-Jacob, H. 2009. The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr. Opin. Struct. Biol. 19: 543-548.
41. Rops, A. L., J. van der Vlag, J. F. Lensen, T. J. Wijnhoven, L. P. van den Heuvel, T. H. van Kuppevelt, and J. H. Berden. 2004. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int. 65: 768-785.
42. Johnson, Z., M. H. Kosco-Vilbois, S. Herren, R. Cirillo, V. Muzio, P. Zaratin, M. Carbonatto, M. Mack, A. Smailbegovic, M. Rose, et al. 2004. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173: 5776-5785.
43. Severin, I. C., A. Soares, J. Hantson, M. Teixeira, D. Sachs, D. Valognes, A. Scheer, M. K. Schwarz, T. N. Wells, A. E. Proudfoot, and J. Shaw. 2012. Glycosaminoglycan analogs as a novel anti-inflammatory strategy. Front. Immunol. 3: 293.
44. Hachet-Haas, M., K. Balabanian, F. Rohmer, F. Pons, C. Franchet, S. Lecat, K. Y. Chow, R. Dagher, P. Gizzi, B. Didier, et al. 2008. Small neutralizing molecules to inhibit actions of the chemokine CXCL12. J. Biol. Chem. 283: 23189-23199.
45. Blanchetot, C., D. Verzijl, A. Mujić-Delić, L. Bosch, L. Rem, R. Leurs, C. T. Verrips, M. Saunders, H. de Haard, and M. J. Smit. 2013. Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function. J. Biol. Chem. 288: 25173-25182.
46. Gonzalo, J. A., C. M. Lloyd, A. Peled, T. Delaney, A. J. Coyle, and J. C. Gutierrez-Ramos. 2000. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J. Immunol. 165: 499-508.